GlassScriptPhysician profile
Neal Krasnick
NPI 1619963188
$1,861.29
in general payments reported to CMS, 2019-2025
25 companies · $245 in 2025
The $245 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $113 · 2021: $196 · 2022: $313 · 2023: $288 · 2024: $349 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $882.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $881.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $502.68 | 2019-2025 | Acrysof Iq Vivity, Acrysof Iq Panoptix Uv Iol, Rocklatan |
| Kala Pharmaceuticals, INC. | $180.32 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $133.36 | 2019-2021 | |
| Dompe US, INC. | $118.18 | 2021-2025 | Oxervate |
| Thea Pharma INC. | $112.06 | 2022-2024 | Iyuzeh |
| Novartis Pharmaceuticals Corporation | $100.53 | 2019-2023 | |
| Bausch & Lomb Americas INC. | $91.34 | 2022-2024 | Miebo, Vyzulta |
| Allergan, INC. | $76.30 | 2019-2022 | |
| Rxsight INC | $72.69 | 2022-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Regeneron Healthcare Solutions, INC. | $64.14 | 2019-2025 | Eylea Hd |
| Sun Pharmaceutical Industries INC. | $58.47 | 2022-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $57.03 | 2019-2022 | |
| New World Medical,INC. | $35.63 | 2023-2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Via360 |
| Tarsus Pharmaceuticals, INC. | $35.60 | 2024 | Xdemvy |
| Sandoz INC. | $30.62 | 2025 | Cimerli |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $26.25 | 2019-2024 | Dextenza |
| Aerie Pharmaceuticals, INC. | $24.22 | 2019 | |
| Harrow Eye, LLC | $23.85 | 2025 | Vevye |
| Abbvie INC. | $22.33 | 2023 | |
| Akorn Operating Company LLC | $19.91 | 2021 | |
| Oyster Point Pharma, INC. | $18.59 | 2022 | |
| Rayner Intraocular Lenses Limited | $17.73 | 2023 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Shire North American Group INC | $15.00 | 2019 | |
| Eyevance Pharmaceuticals LLC | $12.71 | 2022 | |
| Eyepoint US, INC. | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neal Krasnick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.